Updating the Prevalance of Sickle Cell Disease in eSwatini Utilizing Point-of-Care Technology
S
Scott Coven
Primary Investigator
Enrolling By Invitation
100 years and younger
All
Phase
N/A
1000 participants needed
2 Locations
Brief description of study
The purpose of the study is to establish an accurate prevalence of sickle cell disease. We hope to give patients an accurate diagnosis using a rapid and portable diagnostic technique (HemoTypeSC) so that we can begin any needed treatments quickly.
Detailed description of study
Participants will provide a blood sample to be tested for sickle cell disease utilizing HemoTypeSC, and a second blood sample to correlate the findings of the HemoTypeSC.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Sickle Cell Disease, Riley
-
Age: - 100 Years
-
Gender: All
Newborn infants at birth; children up to 12 years of age recruitied from the Health Department of OPD and outyling rural clinics; adults over 18 years of age recruited from the Casualty Department or outlying rural clinics; individuals at least 12 years of age seen at the Adult OPD or outlying rural clinics; pregnant/delivering mothers at least 18 years of age recruited from the maternity ward.
Updated on
12 Sep 2024.
Study ID: 1907058663, PHO-IIR-SCD-ESWATINI
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
